CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $359,000 | +23.4% | 3,511 | +40.4% | 0.20% | +488.2% |
| Q4 2019 | $291,000 | +1.7% | 2,500 | 0.0% | 0.03% | -12.8% |
| Q3 2019 | $286,000 | -81.9% | 2,500 | -84.3% | 0.04% | -50.0% |
| Q2 2018 | $1,579,000 | -32.6% | 15,900 | -45.0% | 0.08% | -37.1% |
| Q1 2018 | $2,342,000 | +5.4% | 28,910 | +2.5% | 0.12% | -8.1% |
| Q4 2017 | $2,221,000 | +86.3% | 28,200 | +118.4% | 0.14% | +66.7% |
| Q3 2017 | $1,192,000 | – | 12,915 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |